library.onepin.app/mots-c Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider

OnePin Peptide Library · Mitochondrial

Mitochondrial Mitochondrial-derived peptide (MDP) Not FDA-approved · investigational

MOTS-c

MOTSc · Mitochondrial-Derived Peptide

Mitochondrial-derived peptide (MDP)Mitochondrial DNA-encoded signaling peptideAMPK pathway activatorExercise and caloric restriction mimetic

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a 16-amino acid peptide encoded by mitochondrial DNA, making it one of only a few known mitochondrial-derived peptides (MDPs). Unlike most peptides and hormones which are encoded by nuclear DNA, MOTS-c is synthesized in response to cellular energy demands, particularly when glucose is scarce or when the body is under metabolic stress. It functions as an exercise mimetic and caloric restriction mimetic, activating AMPK (AMP-activated protein kinase) signaling to enhance glucose metabolism, fatty acid oxidation, and insulin sensitivity. MOTS-c was discovered by Dr. Pinchas Cohen's laboratory at USC and has been characterized as a mitochondrial signaling peptide that communicates metabolic status from mitochondria to the nucleus.

Quick Start
Route
SubQ injection
Start low
5 mg per injection
Frequency
2-3 times per week
Timing
No strict fasting requirement. Fasting may enhance AMPK activation since MOTS-c mimics caloric restriction signaling.

Morning dosing or pre-exercise preferred. Mitochondrial peptide acts as exercise mimetic. No strict fasting requirement.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Quick Start
Conservative start
5 mg per injection · SubQ injection · 2-3 times per week
Lowest starting point. Hold about a week to assess tolerance before stepping up.
5 mg per injection
2-3 times per week
Intermediate
Mitochondrial Optimization
5-10 mg · SubQ · Weekly
animal study · Lee et al. 2015 (Cell Metab)
5-10 mg
Weekly
Reconstitution CalculatorU-100
050100u
Draw to
units
01

How it works

MOTS-c activates AMPK (AMP-activated protein kinase), the master cellular energy sensor, through inhibition of the folate-methionine cycle in the de novo purine biosynthesis pathway. This triggers a cascade of metabolic effects: increased glucose uptake into skeletal muscle (independent of insulin), enhanced fatty acid oxidation, improved mitochondrial function, and activation of cellular stress response pathways. MOTS-c also translocates to the nucleus during metabolic stress, directly regulating gene expression related to antioxidant defense (through activation of the Nrf2 pathway) and cellular stress resistance. This dual action (cytoplasmic AMPK activation + nuclear gene regulation) makes MOTS-c unique among metabolic peptides. Endogenous MOTS-c levels decline with age and are acutely elevated by exercise, establishing it as a natural exercise-induced regulator.

MOTS-c activates AMPK (AMP-activated protein kinase), the master cellular energy sensor, through inhibition of the folate-methionine cycle in the de novo purine biosynthesis pathway. This triggers a cascade of metabolic effects: increased glucose uptake into skeletal muscle (independent of insulin), enhanced fatty acid oxidation, improved mitochondrial function, and activation of cellular stress response pathways. MOTS-c also translocates to the nucleus during metabolic stress, directly regulating gene expression related to antioxidant defense (through activation of the Nrf2 pathway) and cellular stress resistance. This dual action (cytoplasmic AMPK activation + nuclear gene regulation) makes MOTS-c unique among metabolic peptides. Endogenous MOTS-c levels decline with age and are acutely elevated by exercise, establishing it as a natural exercise-induced regulator.

02

What to expect

Early
Days 1–7

Days 1-7: Minimal perceptible changes. MOTS-c works through cellular signaling that takes time to manifest. Some users report slightly improved exercise tolerance within the first week.

Mid
Weeks 2–4

Weeks 2-4: Exercise performance improvements become more noticeable. Blood glucose regulation may improve (monitor if tracking). Energy levels during fasted states may stabilize.

Later
Weeks 4–12

Weeks 4-8: Cumulative metabolic effects. Body composition improvements visible when combined with exercise and diet. Insulin sensitivity improvements may be measurable via lab work (HOMA-IR, fasting insulin). Endurance gains peak.

03

Evidence

HumanNo published trials
AnimalStrong
In-vitroPresent
2015The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance · Lee C et al, Cell Metabolism ↗peer reviewed
2021MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis · Reynolds JC et al, Nature Communications ↗peer reviewed
2019The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivity · Kim SJ et al, Physiological Reports ↗peer reviewed
2019Lipids and insulin regulate mitochondrial-derived peptide (MOTS-c) in PCOS and healthy subjects · Ramanjaneya M et al, Clinical Endocrinology ↗peer reviewed
04

The honest take

Exercise mimetic

Strong preclinical support. MOTS-c activates the same AMPK pathway triggered by exercise and is acutely elevated by physical activity in humans. Nature Communications (2021) showed MOTS-c improved physical performance in aged mice.

Anti-aging / longevity

MOTS-c declines with age. Restoring levels in aged animals reverses metabolic decline. Conceptually sound for longevity but no human longevity data.

Insulin sensitizer
Supported

Animal data strongly supports improved insulin sensitivity and glucose uptake. Mechanism (AMPK activation) is well-established. Human data needed.

05

Interactions & stacking

What's safe to combine, and what belongs in a separate pin.

Safe & synergistic

BPC-157Non-overlapping (metabolic vs tissue repair)
GHK-CuNon-overlapping (metabolic vs collagen/remodeling)
GHKNon-overlapping mechanisms
AOD-9604Both target fat metabolism through different pathways

Keep separate

MetforminBoth activate AMPK. Combined AMPK activation could cause excessive glucose lowering. Monitor blood glucose closely. MOTS-c is contraindicated with AMPK-activating drugs by some practitioners.
06

Side effects & safety

Commonly reported

  • Generally very well tolerated (naturally occurring human peptide)
  • Mild injection site irritation
  • Rare reports of transient nausea

Less common & notes

  • MOTS-c is endogenously produced in response to exercise and metabolic stress, suggesting inherent compatibility with human biology.
  • Potential for hypoglycemia if combined with other glucose-lowering agents (metformin, insulin, GLP-1 agonists).
  • Contraindicated with active cancer diagnosis (AMPK activation intersects with cancer metabolism in complex ways).
  • Long-term exogenous dosing data in humans is not available.
07

Pharmacokinetics

Illustrative plasma concentration · 24 h
Half-life
4h
Peak · Tmax
1h
Elimination
20h
Activity
24-48 hours (AMPK activation and gene expression changes persist beyond peptide clearance)

Storage. Reconstituted MOTS-c is stable 30+ days at 2-8°C per high-resolution mass spectrometry (Mohtashami et al., ARVO 2022). The study found intact MOTS-c at highest intensities with no increase in methionine oxidation even at 37°C over 30 days. The commonly repeated '25% degradation in 24 hours' appears to confuse in vivo pharmacokinetic half-life (~1-2 hours after injection) with in-solution chemical stability. Note: Study used dilute HPLC water (12.5 ug/mL); typical reconstitution is ~200x more concentrated. BAC water stability expected comparable or better (benzyl alcohol may add preservative benefit). Lyophilized powder is stable frozen (-20°C) for extended periods. Keep reconstituted solution refrigerated (2-8°C), protect from light, do not freeze after reconstitution.

08

Regulatory status

WADA prohibits MOTS-c under S4 of the Prohibited List (Hormone and Metabolic Modulators). FDA does not approve MOTS-c for any human use. Available through research chemical and compounding channels. Contraindicated for competitive athletes.

Put it to work

Calculate, log & track

Open MOTS-c straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open MOTS-c in the app →

Go deeper

The guide & community

The complete MOTS-c walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community